Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia

Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia

Takashi Ohnishi,1 Akihide Wakamatsu,1 Hisanori Kobayashi2 1Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan; 2Research and Development Clinical Science Division, Janssen Pharmaceutical K.K., Tokyo, JapanCorrespondence: Takashi OhnishiMedical Affairs Division, Janssen Pharmaceutica...

Full description

Bibliographic Details
Main Authors: Ohnishi T, Wakamatsu A, Kobayashi H
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
schizophrenia
social function
functional outcome
long-acting injectable antipsychotics
Online Access:https://www.dovepress.com/early-improvement-of-psychiatric-symptoms-with-long-acting-injectable--peer-reviewed-article-NDT

Internet

https://www.dovepress.com/early-improvement-of-psychiatric-symptoms-with-long-acting-injectable--peer-reviewed-article-NDT

Similar Items